Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases

OncoImmunology

Volumn 5, Issue 6, 2016, Pages

  Sobottka, Bettina ^a   Pestalozzi, Bernhard ^a   Fink, Daniel ^b   Moch, Holger ^a   Varga, Zsuzsanna ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

Breast cancer; lymphocytes; metastasis; tumor profile

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CHILD; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFANT; LUNG METASTASIS; LYMPHOCYTIC INFILTRATION; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84976544263     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1153208     Document Type: Article

References (41)

1. F.M.Blows, K.E.Driver, M.K.Schmidt, A.Broeks, F.E.van Leeuwen, J.Wesseling, M.C.Cheang, K.Gelmon, T.O.Nielsen, C.Blomqvist et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 2010; 7:e1000279; PMID:20520800; 10.1371/journal.pmed.1000279
2. J.Eyles, A.L.Puaux, X.Wang, B.Toh, C.Prakash, M.Hong, T.G.Tan, L.Zheng, L.C.Ong, Y.Jin et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010; 120:2030-9; PMID:20501944; 10.1172/JCI42002
3. Y.Hüsemann, J.B.Geigl, F.Schubert, P.Musiani, M.Meyer, E.Burghart, G.Forni, R.Eils, T.Fehm, G.Riethmüller et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13:58-68; PMID:18167340; 10.1016/j.ccr.2007.12.003
4. X.H.Zhang, M.Giuliano, M.V.Trivedi, R.Schiff, C.K.Osborne. Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res 2013; 19:6389-97; PMID:24298069; 10.1158/1078-0432.CCR-13-0838
5. R.D.Schreiber, L.J.Old, M.J.Smyth. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; 10.1126/science.1203486
6. J.Galon, B.Mlecnik, G.Bindea, H.K.Angell, A.Berger, C.Lagorce, A.Lugli, I.Zlobec, A.Hartmann, C.Bifulco et al. Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours. J Pathol 2014; 232:199-209; PMID:24122236; 10.1002/path.4287
7. B.Mlecnik, M.Tosolini, A.Kirilovsky, A.Berger, G.Bindea, T.Meatchi, P.Bruneval, Z.Trajanoski, W.H.Fridman, F.Pagès et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 2011; 29:610-8; PMID:21245428; 10.1200/JCO.2010.30.5425
8. W.H.Fridman, F.Pagès, C.Sautès-Fridman, J.Galon. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID:22419253; 10.1038/nrc3245
9. J.Galon, A.Costes, F.Sanchez-Cabo, A.Kirilovsky, B.Mlecnik, C.Lagorce-Pagès, M.Tosolini, M.Camus, A.Berger, P.Wind et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; 10.1126/science.1129139
10. J.Galon, H.K.Angell, D.Bedognetti, F.M.Marincola. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 2013; 39:11-26; PMID:23890060; 10.1016/j.immuni.2013.07.008
11. V.N.Kristensen, C.J.Vaske, J.Ursini-Siegel, P.Van Loo, S.H.Nordgard, R.Sachidanandam, T.Sørlie, F.Wärnberg, V.D.Haakensen, Å.Helland et al. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. Proc Natl Acad Sci U S A 2012; 109:2802-7; PMID:21908711; 10.1073/pnas.1108781108
12. + regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat 2011; 130:645-55; PMID:21717105; 10.1007/s10549-011-1647-3
13. S.M.Mahmoud, E.C.Paish, D.G.Powe, R.D.Macmillan, M.J.Grainge, A.H.Lee, I.O.Ellis, A.R.Green. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011; 29:1949-55; PMID:21483002; 10.1200/JCO.2010.30.5037
14. H.R.Ali, E.Provenzano, S.J.Dawson, F.M.Blows, B.Liu, M.Shah, H.M.Earl, C.J.Poole, L.Hiller, J.A.Dunn et al. Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. Ann Oncol 2014; 25:1536-43; PMID:24915873; 10.1093/annonc/mdu191
15. Y.Issa-Nummer, S.Loibl, G.von Minckwitz, C.Denkert. Tumor-infiltrating lymphocytes in breast cancer: A new predictor for responses to therapy. Oncoimmunology 2014; 3:e27926; PMID:25340002; 10.4161/onci.27926
16. C.Denkert, S.Loibl, A.Noske, M.Roller, B.M.Müller, M.Komor, J.Budczies, S.Darb-Esfahani, R.Kronenwett, C.Hanusch et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010; 28:105-13; PMID:19917869; 10.1200/JCO.2009.23.7370
17. N.R.West, K.Milne, P.T.Truong, N.Macpherson, B.H.Nelson, P.H.Watson. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res 2011; 13:R126; PMID:22151962; 10.1186/bcr3072
18. M.Ono, H.Tsuda, C.Shimizu, S.Yamamoto, T.Shibata, H.Yamamoto, T.Hirata, K.Yonemori, M.Ando, K.Tamura et al. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat 2012; 132:793-805; PMID:21562709; 10.1007/s10549-011-1554-7
19. F.S.Hodi, S.J.O'Day, D.F.McDermott, R.W.Weber, J.A.Sosman, J.B.Haanen, R.Gonzalez, C.Robert, D.Schadendorf, J.C.Hassel et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23; PMID:20525992; 10.1056/NEJMoa1003466
20. S.L.Topalian, F.S.Hodi, J.R.Brahmer, S.N.Gettinger, D.C.Smith, D.F.McDermott, J.D.Powderly, R.D.Carvajal, J.A.Sosman, M.B.Atkins et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366:2443-54; PMID:22658127; 10.1056/NEJMoa1200690
21. J.M.Taube, A.Klein, J.R.Brahmer, H.Xu, X.Pan, J.H.Kim, L.Chen, D.M.Pardoll, S.L.Topalian, R.A.Anders. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res 2014; 20:5064-74; PMID:24714771; 10.1158/1078-0432.CCR-13-3271
22. R.H.Vonderheide, P.M.LoRusso, M.Khalil, E.M.Gartner, D.Khaira, D.Soulieres, P.Dorazio, J.A.Trosko, J.Rüter, G.L.Mariani et al. Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells. Clin Cancer Res 2010; 16:3485-94; PMID:20479064; 10.1158/1078-0432.CCR-10-0505
23. + follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest 2013; 123:2873-92; PMID:23778140; 10.1172/JCI67428
24. R.Salgado, C.Denkert, S.Demaria, N.Sirtaine, F.Klauschen, G.Pruneri, S.Wienert, G.Van den Eynden, F.L.Baehner, F.Penault-Llorca et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol 2014; 26:259-71; PMID:25214542; 10.1093/annonc/mdu450
25. J.Goc, W.H.Fridman, C.Sautès-Fridman, M.C.Dieu-Nosjean. Characteristics of tertiary lymphoid structures in primary cancers. Oncoimmunology 2013; 2:e26836; PMID:24498556; 10.4161/onci.26836
26. B.Weigelt, J.L.Peterse, L.J.van 't Veer. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5:591-602; PMID:16056258; 10.1038/nrc1670
27. E.Y.Lin, J.W.Pollard. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 2007; 67:5064-6; PMID:17545580; 10.1158/0008-5472.CAN-07-0912
28. J.W.Pollard. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4:71-8; PMID:14708027; 10.1038/nrc1256
29. T.Pukrop, F.Dehghani, H.N.Chuang, R.Lohaus, K.Bayanga, S.Heermann, T.Regen, D.Van Rossum, F.Klemm, M.Schulz et al. Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia 2010; 58:1477-89; PMID:20549749; 10.1002/glia.21022
30. D.G.DeNardo, J.B.Barreto, P.Andreu, L.Vasquez, D.Tawfik, N.Kolhatkar, L.M.Coussens. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009; 16:91-102; PMID:19647220; 10.1016/j.ccr.2009.06.018
31. A.Cimino-Mathews, X.Ye, A.Meeker, P.Argani, L.A.Emens. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study. Hum Pathol 2013; 44:2055-63; PMID:23701942; 10.1016/j.humpath.2013.03.010
32. S.Liu, J.Lachapelle, S.Leung, D.Gao, W.D.Foulkes, T.O.Nielsen. CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Res 2012; 14:R48; PMID:22420471; 10.1186/bcr3148
33. N.Hiraoka, Y.Ino, R.Yamazaki-Itoh, Y.Kanai, T.Kosuge, K.Shimada. Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer. Br J Cancer 2015; 112:1782-90; PMID:25942397; 10.1038/bjc.2015.145
34. D.Schrama, P.thor Straten, W.H.Fischer, A.D.McLellan, E.B.Bröcker, R.A.Reisfeld, J.C.Becker. Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001; 14:111-21; PMID:11239444; 10.1016/S1074-7613(01)00094-2
35. M.C.Dieu-Nosjean, M.Antoine, C.Danel, D.Heudes, M.Wislez, V.Poulot, N.Rabbe, L.Laurans, E.Tartour, L.de Chaisemartin et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008; 26:4410-7; PMID:18802153; 10.1200/JCO.2007.15.0284
36. L.de Chaisemartin, J.Goc, D.Damotte, P.Validire, P.Magdeleinat, M.Alifano, I.Cremer, W.H.Fridman, C.Sautès-Fridman, M.C.Dieu-Nosjean. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 2011; 71:6391-9; PMID:21900403; 10.1158/0008-5472.CAN-11-0952
37. D.Coppola, M.Nebozhyn, F.Khalil, H.Dai, T.Yeatman, A.Loboda, J.J.Mulé. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol 2011; 179:37-45; PMID:21703392; 10.1016/j.ajpath.2011.03.007
38. H.Kennecke, R.Yerushalmi, R.Woods, M.C.Cheang, D.Voduc, C.H.Speers, T.O.Nielsen, K.Gelmon. Metastatic behavior of breast cancer subtypes. J Clin Oncol 2010; 28:3271-7; PMID:20498394; 10.1200/JCO.2009.25.9820
39. K.E.de Visser, L.V.Korets, L.M.Coussens. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005; 7:411-23; PMID:15894262; 10.1016/j.ccr.2005.04.014
40. + T cells to T-regulatory cells. Cancer Res 2011; 71:3505-15; PMID:21444674; 10.1158/0008-5472.CAN-10-4316
41. J.A.Coronella-Wood, E.M.Hersh. Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother 2003; 52:715-38; PMID:12920480; 10.1007/s00262-003-0409-4